Decrease of TET2 expression and increase of 5-hmC levels in myeloid sarcomas

Leukemia Research

Volumn 42, Issue , 2016, Pages 75-79

  Xiao, Desheng ^a   Shi, Ying ^a,b,c   Fu, Chunyan ^a   Jia, Jiantao ^a,d   Pan, Yu ^a   Jiang, Yiqun ^a,b,c   Chen, Ling ^a,b,c   Liu, Shuang ^a   Zhou, Wen ^a,b,c   Zhou, Jianhua ^a   Tao, Yongguang ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c National Health and Family Planning Commission   (China)

^d Changzhi School of Medicine   (China)

Author keywords

5 hmC; CD34; CD68; Myeloid sarcoma; Myeloperoxidase; TET2

Indexed keywords

5 METHYLCYTOSINE; CD34 ANTIGEN; CD68 ANTIGEN; MYELOPEROXIDASE; REGULATOR PROTEIN; STEM CELL FACTOR RECEPTOR; TEN ELEVEN TRANSLOCATION 2 PROTEIN; UNCLASSIFIED DRUG; 5-HYDROXYMETHYL-2'-DEOXYCYTIDINE; CD68 ANTIGEN, HUMAN; DEOXYCYTIDINE; DIFFERENTIATION ANTIGEN; DNA BINDING PROTEIN; FORMALDEHYDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 3; LEUKOCYTE ANTIGEN; MYELOPOIETIN; ONCOPROTEIN; PARAFFIN; TET2 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GRANULOCYTIC SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; ADULT; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; MIDDLE AGED; SARCOMA, MYELOID; TISSUE FIXATION; YOUNG ADULT;

5-METHYLCYTOSINE; ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOMARKERS, TUMOR; DEOXYCYTIDINE; DNA-BINDING PROTEINS; FEMALE; FORMALDEHYDE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-3; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; SARCOMA, MYELOID; TISSUE FIXATION; YOUNG ADULT;

EID: 84960796265     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2016.01.002     Document Type: Article

References (31)

1. Delatte B., Deplus R., Fuks F. Playing TETris with DNA modifications. EMBO J. 2014, 33(Jun. 11):1198-1211.
2. Solary E., Bernard O.A., Tefferi A., Fuks F., Vainchenker W. The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 2014, 28(Mar. 3):485-496.
3. Delhommeau F., Dupont S., Della Valle V., James C., Trannoy S., Masse A. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 2009, 360(May 22):2289-2301.
4. Moran-Crusio K., Reavie L., Shih A., Abdel-Wahab O., Ndiaye-Lobry D., Lobry C. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011, 20(Jul. 1):11-24.
5. Shen L., Zhang Y. 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. Curr. Opin. Cell Biol. 2013, 25(Jun. 3):289-296.
6. Ruzov A., Tsenkina Y., Serio A., Dudnakova T., Fletcher J., Bai Y. Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development. Cell Res. 2011, 21(Sep. 9):1332-1342.
7. Koh K.P., Yabuuchi A., Rao S., Huang Y., Cunniff K., Nardone J. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011, 8(Feb. 2):200-213.
8. Pileri S.A., Ascani S., Cox M.C., Campidelli C., Bacci F., Piccioli M. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007, 21(Feb. 2):340-350.
9. Drexler H.G., MacLeod R.A. Malignant hematopoietic cell lines: in vitro models for the study of mast cell leukemia. Leuk. Res. 2003, 27(Aug. 8):671-676.
10. Fujieda A., Nishii K., Tamaru T., Otsuki S., Kobayashi K., Monma F. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature. Leuk. Res. 2006, 30(Aug. 8):1053-1057.
11. Mirza M.K., Sukhanova M., Stolzel F., Onel K., Larson R.A., Stock W. Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays. Leuk. Res. 2014, 38(Sep. 9):1091-1096.
12. Riddle A., Olsen B. Erythroblastic sarcoma. Leuk. Res. 2012, 36(Aug. 8):e182-184.
13. Schafer H.S., Becker H., Schmitt-Graff A., Lubbert M. Granulocytic sarcoma of core-binding factor (CBF) acute myeloid leukemia mimicking pancreatic cancer. Leuk. Res. 2008, 32(Sep. 9):1472-1475.
14. Ueda K., Ichikawa M., Takahashi M., Momose T., Ohtomo K., Kurokawa M. FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy. Leuk. Res. 2010, 34(Sep. 9):1239-1241.
15. Zhang X.H., Zhang R., Li Y. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature. Leuk. Res. 2010, 34(Jul. 7):958-961.
16. Campidelli C., Agostinelli C., Stitson R., Pileri S.A. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am. J. Clin. Pathol. 2009, 132(Sep. 3):426-437.
17. Ohanian M., Faderl S., Ravandi F., Pemmaraju N., Garcia-Manero G., Cortes J. Is acute myeloid leukemia a liquid tumor?. Int. J. Cancer 2013, 133(Aug. 3):534-543.
18. Stefanidakis M., Karjalainen K., Jaalouk D.E., Gahmberg C.G., O'Brien S., Pasqualini R. Role of leukemia cell invadosome in extramedullary infiltration. Blood 2009, 114(Oct. 14):3008-3017.
19. Yilmaz A.F., Saydam G., Sahin F., Baran Y. Granulocytic sarcoma: a systematic review. Am. J. Blood Res. 2013, 3(4):265-270.
20. Klug M., Schmidhofer S., Gebhard C., Andreesen R., Rehli M. 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes. Genome Biol. 2013, 14(5):46.
21. Toumeh A., Phinney R., Kobalka P., Mohamed I. Bilateral myeloid sarcoma of the breast and cerebrospinal fluid as a relapse of acute myeloid leukemia after stem-cell transplantation: a case report. J. Clin. Oncol. 2012, 30(Aug. 22):199-201.
22. Chang C.C., Eshoa C., Kampalath B., Shidham V.B., Perkins S. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow. Am. J. Clin. Pathol. 2000, 114(Nov. 5):807-811.
23. Astall E., Yarranton H., Arno J., Marcus R. Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34. J. Clin. Pathol. 1999, 52(Sep. 9):705-707.
24. Pronier E., Almire C., Mokrani H., Vasanthakumar A., Simon A., da Costa Reis Monte Mor B. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood 2011, 118(Sep. 9):2551-2555.
25. Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468(Dec. 7325):839-843.
26. Spruijt C.G., Gnerlich F., Smits A.H., Pfaffeneder T., Jansen P.W., Bauer C. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152(Feb. 5):1146-1159.
27. Yu W., McIntosh C., Lister R., Zhu I., Han Y., Ren J. Genome-wide DNA methylation patterns in LSH mutant reveals de-repression of repeat elements and redundant epigenetic silencing pathways. Genome Res. 2014, 24(Oct. 10):1613-1623.
28. Xi S., Geiman T.M., Briones V., Guang Tao Y., Xu H., Muegge K. Lsh participates in DNA methylation and silencing of stem cell genes. Stem Cells 2009, 27(Nov. 11):2691-2702.
29. Tao Y., Xi S., Shan J., Maunakea A., Che A., Briones V., et al. Lsh, chromatin remodeling family member, modulates genome-wide cytosine methylation patterns at nonrepeat sequences. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(Apr. 14):5626-5631.
30. Tao Y., Xi S., Briones V., Muegge K. Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation. PLoS One 2010, 5(2):e9163.
31. Ren J., Briones V., Barbour S., Yu W., Han Y., Terashima M. The ATP binding site of the chromatin remodeling homolog Lsh is required for nucleosome density and de novo DNA methylation at repeat sequences. Nucleic Acids Res. 2015, 43(Feb. 3):1444-1455.